Objective: To compare the effectiveness of the second-generation long-acting injectable antipsychotic paliperidone palmitate with the older long-acting injectable antipsychotic haloperidol decanoate.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback